Controversies in the treatment of breast cancer with CDK4/CDK6 inhibitors
The ebb and flow of adjuvant trials
0 COMENTÁRIOSSee more Clinical Trials
Adjuvant nivolumab in cancer of the esophagus and esophagogastric junction
Interim analysis of the CheckMate 577 study
1 COMENTÁRIOS
Overcoming resistance to endocrine therapy in advanced breast cancer
Inhibition of CDK-4 / CDK-6
1 COMENTÁRIOS
When a clinical trial turns into a win-win game
Her-2 dual blockade strategy in the curative treatment of early breast cancer
2 COMENTÁRIOS